Internationally Renowned Cancer and Stem Cell Researcher to Lead Bronx-Based NCI-Designated Center.

Media release from Albert Einstein College of Medicine:

We are proud to announce that Ulrich Steidl, M.D., Ph.D., an international leader in blood cancer and stem cell research, has been named director of the Montefiore Einstein Comprehensive Cancer Center (MECCC) and vice president of cancer medicine at Montefiore Health System.

Dr. Steidl has served as interim director since late 2025 and previously held multiple leadership roles within MECCC, a National Cancer Institute (NCI)-designated comprehensive cancer center. Since joining Montefiore Einstein in 2008, he has built a distinguished career advancing our understanding of pre-leukemic stem cells and developing innovative approaches to cancer prevention and treatment.

His pioneering research has helped shape the concept of “precision prevention” and contributed to therapies now in clinical trials. An inventor on numerous patents and a co-founder of successful biotech startups, Dr. Steidl is also a dedicated mentor and collaborator. He has received numerous honors, including awards from the National Cancer Institute, Blood Cancer United, the International Society for Experimental Hematology (ISEH), and the V Foundation for Cancer Research, and is an elected member of the Association of American Physicians and the American Society for Clinical Investigation.

“I am deeply honored to accept the leadership of MECCC,” said Dr. Steidl. “We have a tremendous team composed of exceptional clinicians, researchers, and administrators who are deeply dedicated to our patients, our community, and cutting-edge cancer care and innovative science. I look forward to working together as we advance our mission to reduce the burden of cancer in the Bronx and beyond, and drive innovation that improves the lives and well-being of people in our borough and around the world.”

To read more, visit: montefioreeinstein.org/ulrich-steidl

Albert Einstein College of Medicine: einsteinmed.edu

Montefiore Einstein: montefioreeinstein.org

Photo: ©Montefiore (Corrected!)

All rights belong to: (for this news)

Ulrich G. Steidl, M.D., Ph.D.

Albert Einstein College of Medicine

Montefiore Einstein

Dyspnea Symposium will take place at the Gottlieb Duttweiler Institute in Rüschlikon - an interdisciplinary exchange around the complex symptom dyspnea.

Media release from Universitätsspital Zürich:

On May 30, 2026, the Dyspnea Symposium will take place at the Gottlieb Duttweiler Institute in Rüschlikon - an interdisciplinary exchange around the complex symptom dyspnea.

Participants can expect a varied program with current scientific updates, practical workshops and exciting discussions. The focus is on the diverse causes of respiratory distress as well as their diagnostic and therapeutic approaches in everyday clinical practice.

The event is aimed at medical professionals and offers an ideal platform for knowledge transfer, networking and the exchange of information on current developments in pneumology.

More on our website: usz.ch/veranstaltung/dyspnoe-symposium-2026

Universitätsspital Zürich: usz.ch

LUNGE ZÜRICH: lunge-zuerich.ch

Photo: © USZ

All rights belong to: (for this news)

Universitätsspital Zürich - LUNGE ZÜRICH

Organization owner & Team on organizing

The 24th National Congress of Surgery was successfully held in Antalya.

Media release from Turkish Surgical Association:

The 24th National Congress of Surgery was successfully held in Antalya.

The congress, attended by former and current surgical directors, addressed the training of surgical assistants, the problems they face, and proposed solutions.

for more: uck2026.org/EN

TCD (Turkish Surgical Association): turkcer.org.tr

Photo: ©TCD

All rights belong to: (for this news)

TCD (Turkish Surgical Association)

24th National Congress of Surgery - Organization owner & Team on organizing

Participants were happy to come together on this meaningful day, which draws attention to the importance of professional solidarity and unity.

Media release from SANKO University: (Original text)

A meaningful celebration program was held on the occasion of April 8 Physiotherapists' Day in the organization of the Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation and Fizyolife Club. The event, which gained meaning with the participation of the Gaziantep Provincial Representative of the Turkish Physiotherapists Association (TFD), Specialist Physiotherapist Yakup Can Ayçin, and his valuable messages emphasizing the importance of the profession, attracted great attention.

Within the scope of the program, the place and importance of the physiotherapy profession in the field of health and its contributions to patient quality of life were discussed, and inspiring shares were made that increased professional motivation for students. Participants were happy to come together on this meaningful day, which draws attention to the importance of professional solidarity and unity.

To the event; Our Rector Prof. Dr. Güner Dağlı, our Secretary General Dr. Yusuf Ziya Yıldırım and our Dean of the Faculty of Medicine Prof. Dr. Salih Murat Akkın also attended.

SANKO University: sanko.edu.tr/en

Photo: ©SANKO

“All rights belong to SANKO Üniversitesi” (for this news)

The 1st Halle Symposium for Emergency Medicine will create a new platform for interdisciplinary exchange in emergency medicine.

Media release from Universitätsmedizin Halle:

With the 1st Halle Emergency Medicine Symposium (HaNSy), we aim to create a new platform for interdisciplinary exchange in emergency medicine.

Under the overarching theme of “Rescue service of the future”, the focus is on practical presentations and a panel discussion with representatives from hospitals, emergency services, professional associations and air rescue.

The report sheds light on current and controversial topics as well as structural developments of the coming years.

Together with experts from different healthcare sectors, challenges are analyzed, opportunities are identified, and concrete solutions for the future of emergency care are discussed.

May 12, 2026

for more: hallenser-notfallmedizin-symposium-hansy

Organizer: University Clinic for Anesthesiology and Surgical Intensive Care

Universitätsmedizin Halle: umh.de

Medizinischen Fakultät der Martin-Luther-Universität Halle-Wittenberg: medfak.uni-halle.de

Medizinischen Fakultät Halle: umh.de/medizinische-fakultaet

Photo: ©Universitätsmedizin Halle

All rights belong to: (for this news)

Universitätsmedizin Halle - 1. Hallenser Notfallmedizin-Symposium (HaNSy)

Universitätsklinik für Anästhesiologie und Operative Intensivmedizin

Deutsche Akademie der Naturforscher Leopoldina e. V

The KBGGG/SRMBL - Forensic Scientific Afternoon 2026 is a scientific event intended for professionals active in forensic medical, judicial, and forensic sciences.

Media release from Royal Belgian Society of Legal Medicine (SRMLB-KBGGG):

Forensic Scientific Afternoon & Gala Cocktail Dinner 2026

The KBGGG/SRMBL - Forensic Scientific Afternoon 2026 is a scientific event intended for professionals active in forensic medical, judicial, and forensic sciences.

This annual meeting aims to promote sharing knowledge, interdisciplinary dialogue, and professional exchange in a context where scientific, legal, and ethical challenges are rapidly evolving.

This event is organized by the Royal Belgian Society of Legal Medicine (KBGGG/SRMLB) and combines a scientific afternoon session with a networking walking dinner, bringing together Belgian and international experts.

The presentations will take place in English.

Registration is now open for the KBGGG / SRMLB Forensic Scientific Afternoon & Gala Dinner 2026!

The Royal Belgian Society of Legal Medicine (KBGGG / SRMLB) is pleased to welcome professionals, researchers, and students to this key annual scientific event.

We warmly encourage participants to submit an abstract for a 10-minute oral presentation and actively contribute to a dynamic and high-level scientific exchange.

Deadline for abstract submission: April 16.

Submit your abstract here: kbgggsrmlb.odoo.com/abstract

Find more information and register here: forensic-scientific-afternoon-2026-1/register

Registration via the LinkedIn event alone is not sufficient — please complete your official registration through the link above.

We look forward to welcoming you in Brussels.

Royal Belgian Society of Legal Medicine (SRMLB-KBGGG): kbgggsrmlb.odoo.com

Dr. Jessica Vanhaebost, President of the Royal Belgian Society of Legal Medicine (SRMLB-KBGGG) said:

"I’m very happy to open registrations for the SRMLB/KBGGG Forensic Scientific Afternoon & Standing Dinner 2026. This will be my first scientific meeting organized as President of the Royal Belgian Society of Legal Medicine, and I truly hope to see many colleagues and friends from the forensic community there. We warmly encourage abstract submissions for 10-minute oral presentations. Looking forward to an inspiring afternoon of forensic science and discussions in Brussels".

Photo: © SRMLB-KBGGG

“All rights belong to Royal Belgian Society of Legal Medicine (SRMLB-KBGGG)” (for this news)

The "Age Well Neighbourhoods" initiative is a significant step toward plugging gaps in senior services, starting with Toa Payoh.

Media release from Duke-NUS Medical School:

As Singapore prepares for a future where one in four citizens will be aged 65 or above by 2030, Assoc Prof Rahul Malhotra and Dr Jeremy Lim-Soh from the Duke-NUS Centre for Ageing Research and Education are looking at how neighbourhoods can better support ageing-in-place.

The "Age Well Neighbourhoods" initiative is a significant step toward plugging gaps in senior services, starting with Toa Payoh. However, effective support goes beyond infrastructure—it requires a shift toward "person-centric" care that respects the unique routines and aspirations of our seniors.

By integrating place-centric policies with a deeper understanding of individual needs, we can create communities where seniors don't just live, but truly thrive with dignity and purpose.

Read more about it from the link: age-well-neighbourhoods

Duke-NUS Medical School: duke-nus.edu.sg

Duke University School of Medicine: medschool.duke.edu

National University of Singapore (NUS): nus.edu.sg

Photo: ©Duke-NUS

“All rights belong to: (for this news)

Duke-NUS Medical School

Assoc Prof Rahul Malhotra

Dr Jeremy Lim-Soh - Duke-NUS Centre for Ageing Research and Education

Initiative "Age Well Neighbourhoods"

The scanner enables detailed analysis of individual cells within tumours, including those that may drive metastasis or express key markers that can inform more effective treatment strategies.

Media release from National Breast Cancer Research Institute:

New Scanner a ‘Game Changer’ for breast cancer research

The exceptional corporate partnership that was formed between the National Breast Cancer Research Institute (NBCRI) and Hewlett Packard Enterprise (HPE), supported by CÚRAM, Research Ireland Centre for Medical Devices and the University of Galway - College of Medicine, Nursing and Health Sciences, has enabled the installation of a cutting-edge multiplex imaging scanner at the Lambe Institute, part of University of Galway.

“This is a ‘Game Changer”, says Director of Research at NBCRI, Professor Michael Kerin. “The scanner enables detailed analysis of individual cells within tumours, including those that may drive metastasis or express key markers that can inform more effective treatment strategies. The purchase of this equipment is a tremendous example of the strength of collaboration, demonstrating how organisations and corporate partnerships such as HPE can make a truly life-changing difference for patients.”

The purchase of this machine, the first in the country, really shows what can be achieved when corporate partnerships, such as HPE and NBCRI develop and make a life changing difference for patients.

The National Breast Cancer Research Institute is a national charity that funds a comprehensive research programme at University of Galway.

Research has improved the diagnosis, treatment options, and outcomes for those who develop breast cancer. The charity funds these research programmes to continue to impact the outcomes for those who develop the disease.

National Breast Cancer Research Institute: NBCRI is a national charity funding a comprehensive breast cancer research programme at University of Galway.

Read the full press release here: new-scanner-a-game-changer-for-breast-cancer-research

To learn more about the scanner, Watch Here: youtu.be/gv2o3YJT5S0 (YouTube)

NBCRI: breastcancerresearch.ie

Media release from University of Galway - College of Medicine, Nursing and Health Sciences:

"A great example of what can be achieved when research, healthcare and industry come together to make a real impact. This new scanner will significantly advance breast cancer research and, ultimately, improve outcomes for patients".

University of Galway - College of Medicine, Nursing and Health Sciences:

medicine-nursing-and-health-sciences

Photo: ©NBCRI

Video: ©NBCRI

All rights belong to: (for this news)

University of Galway - College of Medicine, Nursing and Health Sciences

National Breast Cancer Research Institute (NBCRI)

Hewlett Packard Enterprise (HPE)

CÚRAM, Research Ireland Centre for Medical Devices

Lambe Institute for Translational Research & HRB Clinical Research Facility

The result speaks for itself: rapid recovery, functioning transplants, discharge after a few days – without complications.

Media release from Univ.-Prof. Dr. med. univ. MBA Robert Öllinger:

Four kidney transplants in seven days – robotically!

What was an exception just a few years ago is increasingly becoming reality in Vienna.

At the Clinical Department of Transplantation of the Medical University of Vienna / the University Hospital AKH, ​​four transplants were performed using the DaVinci system within one week: two after living donation, two after post-mortem organ donation.

The result speaks for itself: rapid recovery, functioning transplants, discharge after a few days – without complications.

The dedicated nursing team led by Natalie Libera and the surgical team led by Jakob Eichelter and Robert Öllinger have the most experience in the German-speaking world and are driving a development that has the potential to sustainably change transplant surgery.

The crucial question is no longer whether robotic transplantation will be performed – but how quickly this method will become more widely established.

Also live on April 24, 2026, during the Long Night of Research.

Link: langenachtderforschung.at

Rector of the Medical University of Vienna, Univ.-Prof. Dr. med. univ. Markus Müller says:

"Our new head of transplantation surgery „hits the ground running“ together with his great team Robert Öllinger Natalie Libera Jakob Eichelter".

MedUni Wien: meduniwien.ac.at/web

Photo: ©MedUni Wien

All rights belong to: (for this news)

Medizinische Universität Wien | Universitätsklinikum AKH Wien

Univ.-Prof. Dr. med. univ. Markus Müller | Univ.-Prof. Dr. med. univ. MBA Robert Öllinger

Pflegeteam unter der Leitung von Natalie Libera

OP-Team unter der Leitung von Jakob Eichelter und Robert Öllinger

Congratulations!

SFK Agency | News

The current PhD Call at MedUni Vienna offers a range of exciting opportunities in this field and many more projects in cardiovascular biology.

Media release from Medizinische Universität Wien:

Interested in cardiovascular biology?

The current PhD Call at MedUni Vienna offers a range of exciting opportunities in this field.

Join a research group and work on topics such as:

Elucidating the role of IgG antibodies in atherosclerosis (with Florentina Porsch & Christoph Binder)

Investigating how dyslipidemia affects hematopoiesis in the skull (with Máté Kiss)

…and many more projects in cardiovascular biology.

Become part of an international research environment, contribute to cutting-edge science, and take the next step in your academic career.

Find all projects and apply here: open-phd-positions

MedUni Wien: meduniwien.ac.at/web/

Photo: ©MedUni Wien

“All rights belong to Medizinische Universität Wien” (for this news)

The winner of the German Cancer Prize 2026 in the category “Health Services Research” is Professor Dr. med. Jochen Schmitt

Media release from Innovationsausschuss (IA):

German Cancer Prize 2026

The German Cancer Prize has been awarded annually since 1986 for outstanding work in German-speaking countries in the following categories:

-Experimental basic oncological research

-Translational research

-Tumor diagnostics and treatment

-Health services research

The winner of the German Cancer Prize 2026 in the category “Health Services Research” is Professor Dr. med. Jochen Schmitt from TU Dresden as head of the WiZen project funded by the Innovation Committee.

The WiZen project aims to assess the quality of care in certified organ cancer centers compared to non-certified hospitals. Based on (GKV) statutory health insurance billing data and cancer registry data, it has been shown that patients in certified centers have a survival advantage.

With his research, Prof. Dr. med. Schmitt demonstrates how healthcare research can directly improve practice:

- Through the development of new care models

- Methodological groundwork

- Testing of new evidence-based forms of care for patients

The results from WiZen provide important insights into the quality of cancer treatments in certified centers compared to other clinics and give patients guidance in choosing a clinic.

-The resulting insights are highly relevant for those affected, service providers, payers, health policy and society as a whole.

The Innovation Committee congratulates Professor Dr. med. Jochen Schmitt and the WiZen project team on their recognition and their crucial contribution to healthcare research in Germany.

Further information about the project can be found here:

innovationsfonds.g-ba.de/projekte/wizen

Innovationsausschuss (IA):

innovationsfonds.g-ba.de

Photo: ©Jochen Schmitt

All rights belong to: (for this news)

Innovationsausschuss (IA) | G - BA | WiZen project & team | Prof. Dr. med. Jochen Schmitt

The Prof. Dr. Suphi Artunkal Prize, considered the most prestigious award in nuclear medicine in Turkey, was awarded to Prof. Dr. Çiğdem Soydal and her team.

Media release from Medical Faculty of Ankara University:

Highest award in nuclear medicine for Prof. Dr. Çiğdem Soydal

The Medical Faculty of Ankara University has received another prestigious award. A multicenter study led by Prof. Dr. Çiğdem Soydal, a member of the Faculty of Nuclear Medicine, has been awarded the "Prof. Dr. Suphi Artunkal Award".

At the awards ceremony during the National Congress of Nuclear Medicine, the Prof. Dr. Suphi Artunkal Prize, considered the most prestigious award in the field of nuclear medicine in Turkey, was awarded this year to our faculty member Prof. Dr. Çiğdem Soydal and her team.

for more: medicine.ankara.edu.tr/2026/04/08/prof-dr-cigdem-soydal

Medical Faculty of Ankara University: medicine.ankara.edu.tr

Photo: © AÜ

“All rights belong to Medical Faculty of Ankara University” (for this news)

Media release from Helios Kliniken:

Biological aortic valves do not last indefinitely. If further intervention becomes necessary, the treatment decision requires a sound basis. This is precisely what the international REPEAT study is working on. This year's World Health Day focuses on strengthening science as the foundation for better health. This is also the aim of this study.

Helios participates in this through the Helios Health Institute. There, Helios consolidates clinical studies and health research. The institute supports research projects and works with healthcare data from everyday clinical practice to make medical findings applicable to patient care.

This is relevant for cardiology because the study addresses a specific question in patient care that has not yet been answered by a direct randomized controlled trial with long-term follow-up. The REPEAT trial aims to contribute to a more reliable data basis for future decisions regarding repeat interventions on biological aortic valves.

Prof. Dr. med. Michael A. Borger, PhD, Medical Director, Director of the University Clinic for Cardiac Surgery & Professor of Cardiac Surgery at the University of Leipzig, says:

"Our international collaboration shows how research can work across borders – and how we can jointly develop therapies that bring real long-term benefits to our patients"

for more: helios-gesundheit.de

Photo: ©Helios

“All rights belong to Helios Kliniken GmbH” (for this news)

As part of the events for Cancer Awareness Week from April 1st to 7th, the Alanya Training and Research Hospital opened an information stand.

Alanya Education and Research Hospital:

As part of the events for Cancer Awareness Week from April 1st to 7th, the Alanya Training and Research Hospital opened an information stand at the hospital entrance to raise awareness of the importance of early detection and diagnosis.

On the occasion of today's event, Chief Physician Prof. Dr. Banu Karakuş Yılmaz said:

“We remain committed to educating the public about cancer types, symptoms, treatment methods, and prevention. Raising public awareness is one of the most effective measures in the fight against cancer. After cardiovascular diseases, cancer is one of the leading causes of death. However, I would like to emphasize that many cancers are treatable and, with early detection, even completely curable. Worldwide, prostate, lung, and colorectal cancers are most common in men, while breast, lung, and colorectal cancers are most common in women. Early detection is our strongest weapon in the fight against cancer. Many cancers, such as breast, cervical, and colorectal cancers, can be detected at an early stage thanks to regular screenings. This significantly increases treatment success rates. Remember: tomorrow could be too late. Early detection saves lives. We will continue to monitor your health and are always there for you.”

for more: alanyaeah.saglik.gov.tr

Photo: ©EAH

“All rights belong to Alanya Eğitim ve Araştırma Hastanesi” (for this news)

Johanna Strobl from the University Clinic for Dermatology of the MedUni of Vienna was awarded the Gerold Stanek Prize, which was awarded for the first time.

According to an announcement by the Medical University of Vienna:

Congratulations! Johanna Strobl from the University Clinic for Dermatology of the MedUni of Vienna was awarded the Gerold Stanek Prize, which was awarded for the first time.

The “Gerold Stanek Prize for Excellence in Research on Tick-Borne Diseases” recognizes the excellent scientific achievements by young researchers in the field of tick-borne diseases.

Learn more: meduniwien.ac.at

Medical University of Vienna: meduniwien.ac.at/web/

Photo: ©MedUni

“All rights belong to Medizinische Universität Wien” (for this news)

Report by Martin Spranck, Managing Director of the German Children's Cancer Foundation and the German Children's Cancer Association, on LinkedIn!

How does cancer actually develop, starting from just a single cell?

Many people imagine cancer as something that suddenly "appears."

However, the reality is much more subtle and complex.

Cancer often begins with a single cell and a small mistake.

Or more precisely: with several.

Our cells follow clear rules: They divide when necessary, they repair themselves when something is damaged.

And they stop when something stops working.

This system is highly precise.

Cancer develops when this control mechanism is gradually lost.

What exactly happens?

The accelerator pedal gets stuck.

(Proto-oncogenes)

Certain signals cause cells to divide. If these signals are permanently active, the cell continues to grow even though it shouldn't.

The brakes fail (tumor suppressor genes).

Other mechanisms stop growth and repair damage. If they stop working, control is lost.

The cell no longer dies.

Normally, defective cells self-destruct. Cancer cells circumvent this protective mechanism.

These changes don't happen all at once. They build up over years, and eventually the system collapses.

One cell becomes two, two become many, and many become a tumor.

Over time, something crucial happens:

These cells begin to sustain themselves. They ensure that new blood vessels form so they can continue to grow.

Cancer is therefore not a single mistake.

It is more of a process, a slow loss of control.

Or to put it another way: Cancer develops when cells cease to be part of a team as team players and begin to live only for themselves.

I'm interested in your perspective:
What scientific insights would you like to add here? Because I'm neither a doctor nor a biologist.

Martin Spranck on LinkedIn: martin-spranck

Photo: ©Martin Spranck

“All rights belong to Martin Spranck” (for this news)

Call for Submissions: Qbtech ADHD Award – 5th German Psychotherapy Congress 2026 / Deutscher Psychotherapie Kongress.

"Prof. Dr. Christina Schwenck will give a lecture on selective mutism at DPK2026"

This award celebrates innovative work at the intersection of ADHD research, clinical practice, and lived experience, with special emphasis on:

-Translating scientific evidence into practice

-Participatory approaches (co-creation with patients, families, practitioners)

-Self-regulation and sustainable care strategies

-Reducing ADHD-related stigma

Researchers, clinicians, patient advocacy groups, and interdisciplinary teams are invited to apply. The deadline for submissions is March 30 2026; winners will be announced at the congress and receive visibility among ~2,000 attendees.

-An excellent opportunity to showcase impactful innovation in ADHD care and build cross-disciplinary connections!

-Apply now for the Qbtech ADHD Award at the DPK2026 and bring research into practice!

How can we bring scientific insights into practice faster?

The Mental Health Game Jam of the 5th German Psychotherapy Congress creates exactly that kind of space: in 48 hours, initial interactive prototypes for mental health are developed from research ideas.

The English version Info of DPK 2026-Photo Gallery: sfk.tr/galleries/

Photo: ©Deutscher Psychotherapie Kongress

Submit your proposal to: dpk@eventlab.org

German Psychotherapy Congress: deutscher-psychotherapie-kongress.de

German Psychotherapy Congress - Forum for Clinical Psychology and Psychotherapy

Conference organization: event lab. GmbH

All rights belong to: (for this news)

Deutscher Psychotherapie Kongress - Organization owner & Team on organizing

The Federal Association of German Pharmacists' Associations stated that 150,000 people had signed the petition.

ABDA - Bundesvereinigung Deutscher Apothekerverbände e. V.:

150,000 people have signed the petition. This sends a clear signal: Local pharmacies enjoy the highest level of trust among the population.

With this support, we will confidently advocate for our demands and ensure that policymakers can no longer ignore the need for effective economic strengthening of pharmacies. To fully realize our potential, we are now turning up the volume even more. Because every additional voice gives us more weight.

Therefore, we ask you to share the link to the petition in your pharmacy, with your network, and with your customers. Together, we can strengthen our position and secure the future of pharmaceutical care:

Link: openpetition.de

All information regarding the transparency notice can be found at: gesundheitsichern.de

to the YouTube channel: @GesundheitSichern

This is a political advertisement. It was commissioned by the ABDA (Federal Association of German Pharmacists). The advertisement refers to a pharmacy reform planned by the Federal Government.

All rights belong to the campaign owner, sponsor, and political advertisement.

What does the Working Group for Gynecological Oncology e.V. do?

The video interviews from the AGO State of the Art Meeting 2026 are now online!

On March 14, 2026, the Working Group of Gynecological Oncologists (AGO Mamma) presented its new, evidence-based therapy recommendations (guidelines), which were evaluated by the expert commission.

On this occasion, Renate Haidinger of Breast Cancer Germany e.V. was able to discuss the latest recommendations with numerous commission members, who are also the respective heads of their respective departments. The AGO Mamma (Breast Cancer Working Group) consists of 47 commission members from various medical specialties. The recommendations are developed on a voluntary basis following a thorough review and analysis of newly available data.

Numerous interviews on the topics covered and the new guidelines for 2026 can be found on the YouTube channel of Breast Cancer Germany e.V. in the playlist AGO2026.

The video interviews from the AGO State of the Art Meeting 2026 are now online!

Please share! Be sure to check it out!

Web: brustkrebsdeutschland.de/

YouTube: @brustkrebsdeutschlan

Playlist AGO 2026: youtube.com/playlist

“All rights belong to Brustkrebs Deutschland e.V.-AGO2026”

Alanya Education and Research Hospital

Foreign patients trust Turkish Doctors!

In 2025, the Alanya Training and Research Hospital provided healthcare services to 21,102 foreign patients from 112 countries. Due to its high quality and reliability of healthcare, the hospital has become a preferred destination for foreign patients.

Alanya, one of Turkey's most important tourist centers with its rich natural, cultural, and historical offerings, is also distinguished by its excellent healthcare system. The Alanya Teaching and Research Hospital, operated under the auspices of the Ministry of Health in cooperation with a university, enjoys a high reputation for its comprehensive range of healthcare services for international patients.

In a statement on this topic, Chief Physician Prof. Dr. Banu Karakuş Yılmaz explained: “In 2025, we provided medical services to 21,102 foreign patients from 112 countries. Citizens of the Russian Federation most frequently chose our hospital (4,449 patients). They were followed by Ukraine, Germany, Iran and Kazakhstan.”

Professor Dr. Karakuş Yılmaz stated that the departments most frequently visited by foreign patients were the clinics for internal medicine, cardiology, infectious diseases, and general surgery. She also noted that 297 foreign patients underwent successful surgeries in 2025.

Prof. Dr. Karakuş Yılmaz emphasized that her hospital was among the clinics that had qualified for the International Health Tourism Authorization Certificate, and said: “With our translators who speak four different languages, we can continue to offer our foreign patients high-quality, reliable and understandable health services.”

Prof. Dr. Karakuş Yılmaz also explained that the hospital serves a large region encompassing the districts of Anamur, Akseki, Gündoğmuş and Gazipaşa, adding: “In our hospital with a capacity of 420 beds, we provide outpatient services to over a thousand Turkish citizens daily; we continue our efforts to offer the best possible healthcare to both domestic and foreign patients.”

“All rights belong to Alanya Eğitim ve Araştırma Hastanesi”